Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours
- 30 June 2007
- journal article
- clinical trial
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 33 (5), 597-602
- https://doi.org/10.1016/j.ejso.2007.02.021
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Treatment of Unresectable Hepatocellular Carcinoma with Use of 90Y Microspheres (TheraSphere): Safety, Tumor Response, and SurvivalJournal of Vascular and Interventional Radiology, 2005
- Portal Hypertension Secondary to 90Yttrium Microspheres: An Unknown ComplicationJournal of Clinical Oncology, 2005
- Reduction of Metastatic Load to Liver after Intraarterial Hepatic Yttrium-90 Radioembolization as Evaluated by [18F]Fluorodeoxyglucose Positron Emission Tomographic ImagingJournal of Vascular and Interventional Radiology, 2005
- Selective Internal Radiation Therapy with SIR-Spheres® in Patients with Nonresectable Liver TumorsCancer Biotherapy & Radiopharmaceuticals, 2005
- 90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Radioembolization for hepatic metastasesSeminars in Oncology, 2002
- Randomised trial of SIR-Spheres® plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancerAnnals of Oncology, 2001
- Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastasesJournal of Gastrointestinal Surgery, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- REGRESSION OF LIVER METASTASES FOLLOWING TREATMENT WITH YTTRIUM‐90 MICROSPHERESAnz Journal of Surgery, 1992